4th Quarter - Report

TIBER CREEK GROUP for VERTEX PHARMACEUTICALS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General innovation and biotech issues. Rare diseases. ACA Implementation.

LobbyistCovered position, as disclosed
JONATHON JONES —
SEAN RICHARDSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Track and trace drug verification. H.R. 3204, Drug Quality and Security Act.

LobbyistCovered position, as disclosed
JONATHON JONES —
SEAN RICHARDSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3204 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.